Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Más filtros











Base de datos
Intervalo de año de publicación
1.
Asian Pac J Allergy Immunol ; 32(2): 171-7, 2014 Jun.
Artículo en Inglés | MEDLINE | ID: mdl-25003732

RESUMEN

OBJECTIVE: To study changes in immunological responses in patients with CMPA during symptomatic and asymptomatic episodes of cow's milk protein tolerance status. METHODS: 27 CMPA patients were enrolled and underwent diagnostic evaluation, including CM challenge test, skin prick test and specific IgE to CM. Blood samples were collected in two periods from those who became tolerant (n = 13) and those with persistent CMA (n = 14), in order to measure in vitro PBMC responses to cow's milk protein (IL-10, IFN-γ, IL-5), IgG4 to ß-lactoglobulin, casein, BLG-IgG4/IgE ratio and the CAS-IgG4/IgE ratio. RESULTS: Seventy percent of CMPA patients in our study were male with a mean age at diagnosis of 8 months and mean age of onset of 3 months. The reaction time to CM ranged from within 7 minutes to within 14 days. Positive IgE-sensitization was defined as either a specific IgE to CM of more than 0.35 kUA/L (N=11) or SPTs positive for CM and/or fresh cow's milk (N=20). Forty-eight percent of the patients (n = 13) could tolerate CM by 13.38 months (8-19 months). Mean specific-IgE levels to CM were 4.1 kUA/L (range 0.35-14.3 kUA/L). Determination of the cytokine (IL-10, IFN-γ, IL-5) response to BLG revealed significantly higher IL-10 levels during the tolerance phase (212.93 vs 142.46 pg/ml, P = .011). There was a significant increase in BLG-IgG4 and the BLG-IgG4/IgE ratio in the tolerance phase when compared to the symptomatic phase. CONCLUSIONS: IL-10, BLG-IgG4 and the BLG-IgG4/IgE ratio were higher in CMPA patients during the tolerance phase compared to the symptomatic phase.


Asunto(s)
Citocinas/inmunología , Tolerancia Inmunológica , Inmunoglobulina E/inmunología , Inmunoglobulina G/inmunología , Leucocitos Mononucleares/inmunología , Hipersensibilidad a la Leche/inmunología , Proteínas de la Leche/inmunología , Animales , Bovinos , Preescolar , Humanos , Lactante , Recién Nacido , Leucocitos Mononucleares/patología , Masculino , Hipersensibilidad a la Leche/patología
2.
Asian Pac J Allergy Immunol ; 28(1): 53-7, 2010 Mar.
Artículo en Inglés | MEDLINE | ID: mdl-20527517

RESUMEN

The commercially available auto-injector epinephrine is considerable expensive. Epinephrine prefilled syringe is an alternative treatment for anaphylaxis patients. The objective of the present study was to evaluate the stability and sterility of epinephrine prefilled syringe. Epinephrine prefilled syringe was kept in the pencil box to prevent from light exposure. The active ingredients, integrity and level of potency were measured by high-performance liquid chromatography (HPLC). The sterility was accessed by aerobic bacteria and fungi culture. The epinephrine concentration at 1, 2 and 3 months after the preparation was 101.36, 99.31 and 101.09%, respectively (acceptable range 90 - 110%). The pH was 3.17 - 3.23 (acceptable range 2.8 - 3.6). Nor-epinephrine was undetected. The cultures for bacteria and fungus were both negative. Consequently, epinephrine prefilled syringe was stable and sterile at least three month after preparation. Epinephrine prefilled syrine is an alternative low cost treatment for anaphylaxis patient.


Asunto(s)
Estabilidad de Medicamentos , Epinefrina/análisis , Calor , Soluciones Farmacéuticas/química , Jeringas , Anafilaxia/tratamiento farmacológico , Cápsulas , Recuento de Colonia Microbiana , Almacenaje de Medicamentos , Epinefrina/administración & dosificación , Estudios de Factibilidad , Humanos , Soluciones Farmacéuticas/administración & dosificación , Guías de Práctica Clínica como Asunto , Autoadministración , Esterilización , Factores de Tiempo
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA